Spring blossoms and autumn fruits, fragrant osmanthus. On the afternoon of October 16, 2024, Xu Bin, Secretary of the Party Group and Director of the Hefei Municipal Bureau of Industry and Information Technology, and his delegation visited Leecan for inspection and research. Dr. Li Zhengqi, founder and chairman of Leecan, accompanied the research.

    Director Xu Bin and his delegation listened to the report on the development of Leecan and conducted on-site visits and inspections to the R&D laboratory, production workshop, and storage area of Leecan in Nanjing. Director Xu Bin highly appreciates Leecan's entrepreneurial intention of focusing on advanced, complicated and innovative formulations to break monopolies and overcome "bottleneck" technologies. He fully recognizes Leecan's development achievements and speed in the past three years. He hopes that Leecan will keep in mind its original intention, forge ahead, firmly follow the planned goals, achieve high-quality development of the enterprise, and make more contributions to the regional economic and social development.

   Since its establishment, with strong support and assistance from government departments at all levels, Leecan's Nanjing base has reported the production of 11 products, obtained 3 approvals, and achieved commercial production and market sales of 3 products; The Hefei headquarters base has been gradually put into pilot production by the end of August 2024, and multiple projects such as inhalation aerosols, slow-release solid preparations, and complicated injections are progressing in an orderly and rapid manner. It is expected to achieve commercial production by 2026.

  Director Xu Bin's inspection and research not only deepened the understanding between the two sides, but also gave recognition and encouragement to Leecan Pharmaceutical, further strengthening its confidence in development and boosting its development momentum. Leecan will live up to its mission and expectations, continue to deeply cultivate and research in the field of advance, complicated and innovative formulations, and achieve rapid product development and production driven by technological breakthroughs and innovation, meet the needs of the people for medication, improve the quality of life of patients, and strive to make more contributions to Chinese health industry and regional economic and social development!